| 000 | 01545 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513190455.0 | ||
| 264 | 0 | _c19990813 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/01.cir.100.5.553 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRinder, C S | |
| 245 | 0 | 0 |
_aRole of C3 cleavage in monocyte activation during extracorporeal circulation. _h[electronic resource] |
| 260 |
_bCirculation _cAug 1999 |
||
| 300 |
_a553-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aBlood Platelets _xmetabolism |
| 650 | 0 | 4 |
_aCD11 Antigens _xdrug effects |
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 |
_aComplement C3a _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aComplement C5a _xantagonists & inhibitors |
| 650 | 0 | 4 | _aExtracorporeal Circulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aNeutrophils _xmetabolism |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xpharmacology |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aRinder, H M | |
| 700 | 1 | _aJohnson, K | |
| 700 | 1 | _aSmith, M | |
| 700 | 1 | _aLee, D L | |
| 700 | 1 | _aTracey, J | |
| 700 | 1 | _aPolack, G | |
| 700 | 1 | _aHiggins, P | |
| 700 | 1 | _aYeh, C G | |
| 700 | 1 | _aSmith, B R | |
| 773 | 0 |
_tCirculation _gvol. 100 _gno. 5 _gp. 553-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.100.5.553 _zAvailable from publisher's website |
| 999 |
_c10388560 _d10388560 |
||